Context:

Katie Doble's journey with stage 4 ocular melanoma highlights the challenges and triumphs of seeking treatment through clinical trials. Diagnosed in 2013, her cancer progressed rapidly despite initial treatments, leading her to explore multiple trial options, ultimately finding success with T-cell-based immunotherapy. Her experience underscores the importance of a supportive medical network and the willingness to navigate the complexities and uncertainties inherent in clinical trials. The process involved significant travel and logistical challenges due to the scarcity of local specialists, but also brought unexpected benefits, such as learning to appreciate life's small moments. Doble's story serves as a testament to the potential life-extending benefits of clinical trials, as she has been cancer-free for over three years and now advocates for greater awareness of this treatment path.

Dive Deeper:

• Katie Doble was diagnosed with stage 1A ocular melanoma in 2013, a rare cancer with limited treatment options; her condition worsened to stage 4 by 2014, leading her to explore clinical trials as an alternative treatment path.

• Despite being given just 16 months to live, Doble's persistence in pursuing clinical trials, particularly a T-cell-based immunotherapy, resulted in significant tumor reduction and eventual remission after a final surgery.

• Her journey through clinical trials was fraught with challenges, including the need for extensive travel due to the lack of local specialists and the financial burden associated with out-of-state treatments.

• Doble's experience highlights the critical role of a strong medical network, as her doctors provided guidance and support in navigating the complex landscape of clinical trials and treatment options.

• Unexpected obstacles, such as being removed from trials due to health complications, taught her the importance of having contingency plans and being mentally prepared for the unpredictable nature of trial participation.

• Throughout her ordeal, maintaining a sense of normalcy and cherishing everyday moments became vital, leading to significant personal milestones such as marriage and home-building, which provided emotional stability and joy.

• Now cancer-free, Doble advocates for clinical trials as a viable treatment option, emphasizing the potential for extended life and improved outcomes, and serves on the Patient Advisory Board for Walgreens Clinical Trials to raise awareness.